Harnessing Innovative Transplant Diagnostics to Improve Patient Outcomes

Innovative transplant diagnostics and novel paradigms that give a clearer picture of a recipient’s immune system at various phases of the transplant journey can enable transplant teams to mitigate some of these challenges and make more accurate and faster donor assessments, as well as more informed and patient-centric decisions post-transplant. The post Harnessing Innovative Transplant…

Read More

Setting the Record Straight on the FDA’s Authority Over Drug Ads

Letters to the Editor is a periodic feature. We welcome all comments and will publish a selection. We edit for length and clarity and require full names. Clarifying the FDA’s Role and Authority Over Direct-to-Consumer Drug Ads While several inaccuracies in the recent opinion piece about direct-to-consumer prescription drug advertisements by KFF Health News’ Elisabeth Rosenthal have been…

Read More

Keys to Provider Patient Communications Amidst President Trump’s Massive Policy Shifts 

Exactly what the administration is ultimately able to accomplish will be anyone’s guess, but here are some key policy and market shifts healthcare leaders and their PR teams should watch closely and be prepared to communicate around.    The post Keys to Provider Patient Communications Amidst President Trump’s Massive Policy Shifts  appeared first on MedCity News.

Read More